HopeStage
Back to all studies
Active Not RecruitingNCT05273996

Stress, mood and thinking skills in older adults with depression

About this titleRead the official source — NCT05273996
Medication studyAges 65+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 65 years.

Listed locations
FarmingtonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 28, 2021
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
75
Sponsor
David Steffens
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 65 Years
Official registry ID
NCT05273996
Official title
Show the full official title

Phenotype Predictors of Cognitive Outcomes in Geriatric Depression

Recruitment & locations

Not recruiting

Farmington

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is David Steffens.

Does this study involve medication?

Yes. The study involves medication, including Sertraline, bupropion, desvenlafaxine.

Who can participate?

Listed age limits: from 65 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies